Search Results - "Qureshi, Sofia"

Feasibility of autologous hematopoietic stem cell transplant in patients aged ≥70 years with multiple myeloma by Bashir, Qaiser, Shah, Nina, Parmar, Simrit, Wei, Wei, Rondon, Gabriela, Weber, Donna M., Wang, Michael, Orlowski, Robert Z., Thomas, Sheeba K., Shah, Jatin, Qureshi, Sofia R., Dinh, Yvonne T., Popat, Uday, Anderlini, Paolo, Hosing, Chitra, Giralt, Sergio, Champlin, Richard E., Qazilbash, Muzaffar H.

“…Abstract We retrospectively analyzed the outcomes of all consecutive patients with myeloma (n = 84) aged ≥70 years who had received autologous hematopoietic…”
Get full text

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma by Bashir, Qaiser, Khan, Hassan, Orlowski, Robert Z., Amjad, Ali Imran, Shah, Nina, Parmar, Simrit, Wei, Wei, Rondon, Gabriela, Weber, Donna M., Wang, Michael, Thomas, Sheeba K., Shah, Jatin J., Qureshi, Sofia R., Dinh, Yvonne T., Popat, Uday, Anderlini, Paolo, Hosing, Chitra, Giralt, Sergio, Champlin, Richard E., Qazilbash, Muzaffar H.

“…A total of 149 patients with multiple myeloma (MM) who received allogeneic hematopoietic stem cell transplantation (allo‐HCT) with myeloablative (MAC; n = 38)…”
Get full text

The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes by Sharma, Manish, Qureshi, Sofia R., Champlin, Richard E., Popat, Uday, Giralt, Sergio, Qazilbash, Muzaffar H.

“…IgD myeloma is a rare subtype of myeloma that is associated with an aggressive course, resistance to chemotherapy, and a poor outcome. We identified 17…”
Get full text

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma by Efebera, Yvonne A, Qureshi, Sofia R, Cole, Suzanne M, Saliba, Rima, Pelosini, Matteo, Patel, Ronak M, Koca, Ebru, Mendoza, Floralyn L, Wang, Michael, Shah, Jatin, Alousi, Amin, Hosing, Chitra, Popat, Uday, Kebriaei, Partow, Anderlini, Paolo, Khouri, Issa F, Champlin, Richard, Giralt, Sergio, Qazilbash, Muzaffar H

“…Despite recent advances, multiple myeloma (MM) remains incurable, and most patients eventually develop progressive disease. Allogeneic hematopoietic stem cell…”
Get full text

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Low Left Ventricular Ejection Fraction by Qazilbash, Muzaffar H, Amjad, Ali Imran, Qureshi, Suhail, Qureshi, Sofia R, Saliba, Rima M, Khan, Ziad U, Hosing, Chitra, Giralt, Sergio A, De Lima, Marcos J, Popat, Uday R, Yusuf, Syed W, Champlin, Richard E

“…A high risk of regimen-related toxicity with allogeneic hematopoietic stem cell transplantation (allo-HSCT) limits this potentially curative treatment for…”
Get full text

Durable remission with salvage second autotransplants in patients with multiple myeloma by Shah, Nina, Ahmed, Fraz, Bashir, Qaiser, Qureshi, Sofia, Dinh, Yvonne, Rondon, Gabriela, Wen, Sijin, Thall, Peter, Khan, Hassan, Giralt, Sergio, Champlin, Richard, Qazilbash, Muzaffar H.

“…BACKGROUND: High‐dose chemotherapy with autologous hematopoietic cell transplant (auto‐HCT) has been shown to improve survival in patients with newly diagnosed…”
Get full text

38 - Safety and Efficacy of a New High-Dose Chemotherapy (HDC) Regimen of Panobinostat (Pano), Gemcitabine (Gem), Busulfan (Bu) and Melphalan (Mel) (Pano/GBM) with Autologous Stem Cell Transplant (ASCT) for Patients (pts) with High-Risk (HR) or Refractory/Relapsed (R/R) Myeloma (MM) – Matched Pair Comparisons with a Concurrent Control Cohort by Nieto, Yago, Yang, Zixi, Valdez, Ben C., Kundu, Suprateek, Bassett, Roland, Barnett, Melissa, Bashir, Qaiser, Ramdial, Jeremy, Saini, Neeraj Y., Srour, Samer A., Im, Jin Seon, Kebriaei, Partow, Popat, Uday R., Gulbis, Alison M., Cool, Rita, Shigle, Terri Lynn, Wallis, Whitney Dale, Yeh, Jason, Delgado, Ruby, Qureshi, Sofia, Lee, Hans C., Manasanch, Elisabet, Orlowski, Robert Z., Thomas, Sheeba K., Shpall, Elizabeth J., Andersson, Borje S., Qazilbash, Muzaffar H.

Get full text

Safety and Efficacy of a New High-Dose Chemotherapy (HDC) Regimen of Panobinostat (Pano), Gemcitabine (Gem), Busulfan (Bu) and Melphalan (Mel) (Pano/GBM) with Autologous Stem Cell Transplant (ASCT) for Patients (pts) with High-Risk (HR) or Refractory/Relapsed (R/R) Myeloma (MM) – Matched Pair Comparisons with a Concurrent Control Cohort by Nieto, Yago, Yang, Zixi, Valdez, Ben C., Kundu, Suprateek, Bassett, Roland, Barnett, Melissa, Bashir, Qaiser, Ramdial, Jeremy, Saini, Neeraj Y., Srour, Samer A., Im, Jin Seon, Kebriaei, Partow, Popat, Uday R., Gulbis, Alison M., Cool, Rita, Shigle, Terri Lynn, Wallis, Whitney Dale, Yeh, Jason, Delgado, Ruby, Qureshi, Sofia, Lee, Hans C., Manasanch, Elisabet, Orlowski, Robert Z., Thomas, Sheeba K., Shpall, Elizabeth J., Andersson, Borje S., Qazilbash, Muzaffar H.

Get full text

Association of bone marrow plasma cell infiltration pre-auto transplant with adverse outcomes in multiple myeloma by Bashir, Qaiser, Parmar, Simrit, Dinh, Yvonne, Qureshi, Sofia, Rondon, Gabriela, Popat, Uday R., Nieto, Yago, Jones, Roy B., Champlin, Richard E., Qazilbash, Muzaffar, Shah, Nina

“…Abstract only 8102 Background: Auto-stem cell transplantation (SCT) has become the standard of care for eligible patients (pts) with multiple myeloma (MM)…”
Get full text

Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant by Beitinjaneh, Amer M., Saliba, Rima, Bashir, Qaiser, Shah, Nina, Parmar, Simrit, Hosing, Chitara, Popat, Uday, Anderlini, Paolo, Dinh, Yvonne, Qureshi, Sofia, Rondon, Gabriela, Champlin, Richard E., Giralt, Sergio A., Qazilbash, Muzaffar H.

“…Abstract The role of donor lymphocyte infusion (DLI) in mediating the graft-versus-myeloma (GvM) effect after allogeneic hematopoietic stem cell transplant…”
Get full text

Survival Disparities Between African-American and Caucasian Patients Treated with Autologous Stem Cell Transplantation for Multiple Myeloma Are Eliminated in the Era of Novel Therapeutics by Ahmed, Sairah, Dinh, Yvonne T, Qureshi, Sofia, Rondon, Gabriela, Bashir, Qaiser, Parmar, Simrit, Avery, Tiffany, Orlowski, Robert Z., Champlin, Richard, Qazilbash, Muzaffar, Shah, Nina

“…Abstract 2017 Multiple myeloma (MM) remains an incurable disease and is the most common hematologic malignancy among African-Americans. In the United States,…”
Get full text

Increased Bone Marrow Plasma Cell Infiltration Pre-Transplant Is Associated with Worse Outcomes in Patients Undergoing High Dose Chemotherapy and Autologous Stem Cell Transplantation for Multiple Myeloma by Shah, Nina, Bashir, Qaiser, Parmar, Simrit, Dinh, Yvonne T, Qureshi, Sofia, Rondon, Gabriela, Popat, Uday R, Nieto, Yago, Jones, Roy, Champlin, Richard, Qazilbash, Muzaffar H.

“…Abstract 4135 Multiple myeloma (MM) is the second most common adult hematologic malignancy. High dose chemotherapy (HDC) and autologous stem cell…”
Get full text

Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation by Jacobs, Ryan W, Saliba, Rima M, Sasaki, Koji, Farhan, Shatha, Armas, Aristides, Shah, Nina D, Bashir, Qaiser, Qureshi, Sofia, Rondon, Gabriela, Hosing, Chitra, Popat, Uday, Parmar, Simrit, Shah, Jatin J, Wang, Michael, Weber, Donna M, Thomas, Sheeba K, Orlowski, Robert Z, Champlin, Richard E, Qazilbash, Muzaffar H

“…Micro-Abstract We report the outcomes of patients with nonsecretory multiple myeloma (NSM) who were treated with autologous hematopoietic stem cell…”
Get full text

A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently by Kazmi, Syed, Lu, Gary, Shah, Nina, Bashir, Qaiser, Parmar, Simrit, Orlowski, Robert Z., Shah, Jatin J, Hosing, Chitra M, Popat, Uday, Dinh, Yvonne T, Qureshi, Sofia, Rondon, Gabriela, Giralt, Sergio, Champlin, Richard, Qazilbash, Muzaffar H.

“…Abstract 4156▪▪This icon denotes a clinically relevant abstract Chromosomal abnormalities detected either by conventional cytogenetics (CC) or interphase…”
Get full text

Response Before Autologous Hematopoietic Stem Cell Transplantation Is An Important Predictor of Outcome in Multiple Myeloma by Farhan, Shatha, Lin, Heather, Baladandayuthapani, Veerabhadran, Shah, Nina, Bashir, Qaiser, Hosing, Chitra M, Popat, Uday, Parmar, Simrit, Dinh, Yvonne T, Qureshi, Sofia, Rondon, Gabriela, Giralt, Sergio, Champlin, Richard, Qazilbash, Muzaffar H.

“…Abstract 4119 The outcome of multiple myeloma (MM) has improved significantly over the last 2 decades due to the availability of several novel agents and an…”
Get full text

Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma by Bashir, Qaiser, Wei, Wei, Chiattone, Alexandre, Rondon, Gabriela, Parmar, Simrit, Shah, Nina, Booc, Ernesto Harold, Yvonne, Dinh, Sofia, Qureshi, Shah, Jatin J, Orlowski, Robert Z., Weber, Donna, Champlin, Richard, Giralt, Sergio, Qazilbash, Muzaffar H.

“…Abstract 4569 Allogeneic hematopoietic cell transplantation (allo HCT) is a potentially curative therapy for multiple myeloma (MM), but has high…”
Get full text

Autologous Hematopoietic Cell Transplantation In Multiple Myeloma Patients Age 70 Years and Older by Bashir, Qaiser, Wei, Wei, Chiattone, Alexandre, Rondon, Gabriela, Parmar, Simrit, Shah, Nina, Booc, Ernesto Harold, Yvonne, Dinh, Sofia, Qureshi, Shah, Jatin J, Orlowski, Robert Z., Weber, Donna, Champlin, Richard, Giralt, Sergio, Qazilbash, Muzaffar H.

“…Abstract 4576 High dose chemotherapy followed by autologous hematopoietic cell transplantation (auto HCT) for multiple myeloma (MM) has shown improved survival…”
Get full text

Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma by Ahmed, Sairah, Lin, Heather, Baladandayuthapani, Veera, Khan, Mubeen A, Lu, Gary, Rondon, Gabriela, Qureshi, Sofia, Dinh, Yvonne T, Bashir, Qaiser, Shah, Nina, Parmar, Simrit, Hosing, Chitra M, Popat, Uday, Giralt, Sergio A, Orlowski, Robert Z., Shah, Jatin J, Champlin, Richard, Qazilbash, Muzaffar H.

“…Abstract 333 Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Despite…”
Get full text

Durable Remission with Salvage Autotransplants in Patients with Multiple Myeloma by Shah, Nina, Ahmed, Khawaja Fraz, Qureshi, Sofia, Shah, Jatin, Orlowski, Robert Z, Weber, Donna M, Hosing, Chitra, Popat, Uday, Alousi, Amin, Champlin, Richard E, Giralt, Sergio, Qazilbash, Muzaffar

“…Abstract 1227 Poster Board I-249 In comparison with single autologous hematopoietic stem cell transplantation (auto HCT), tandem autologous HCT has resulted in…”
Get full text

Outcome of IgD Myeloma After Autologous Hematopoietic Stem Cell Transplantation by Qureshi, Sofia, Sharma, Manish, Hosing, Chitra, Mendoza, Floralyn L, Shah, Jatin, Alousi, Amin, Anderlini, Paolo, Kebriaei, Partow, Khouri, Issa F, Popat, Uday, Lima, Marcos de, Champlin, Richard E, Giralt, Sergio, Qazilbash, Muzaffar H.

“…Abstract 4354 Multiple Myeloma (MM) is a clonal disorder of plasma cells characterized by monoclonal immunoglobulin (Ig) secretion. Immunoglobulin D (IgD) MM…”
Get full text